Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...
Feb 13, 2024
0
8
Over the last decade, several case studies have reported that people with multiple sclerosis (MS) who started antiretroviral therapy for HIV (to keep the virus in check) subsequently found that their MS symptoms had either ...
Dec 21, 2023
0
1
A study of more than 50 babies in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days—rather than within ...
Dec 5, 2023
0
5
Coronaviruses are a global public health risk, with three highly infectious species, including SARS-CoV-2, emerging in the last 20 years. New research by the University of Bristol has shown how an HIV drug could stop many ...
Dec 5, 2023
0
59
As the globe marks another World AIDS Day on Dec. 1, it's crucial to both acknowledge the significant strides made in the global battle against HIV and recognize the persistent challenges that remain. While the United States ...
Dec 4, 2023
0
0
Just over 40 years ago, the first case of acquired immunodeficiency syndrome—more commonly known as AIDS—was reported, setting into motion a worldwide panic about the unknown, devastating disease. At the time, AIDS was ...
Dec 1, 2023
0
0
Results of a qualitative research study into the uptake of PrEP—a drug which stops HIV infecting the body—suggests that more needs to be done to breakdown barriers to access for the potentially lifesaving medication.
Dec 1, 2023
0
0
Across the 30 countries of the European Union and European Economic Area (EU/EEA), 22,995 new HIV diagnoses were reported in 2022. Almost every second new HIV diagnosis (49%, n=11,103) was among migrants, i.e., among people ...
Nov 30, 2023
0
0
Kenyan authorities issued a warning Wednesday about the sale of counterfeit HIV prevention drugs in the country, saying their "safety, quality and efficacy cannot be assured."
Nov 22, 2023
0
0
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to UC Francisco researchers leading the largest U.S. evaluation of the impact of the public health ...
Nov 15, 2023
0
0
